Trial Profile
A Phase II, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of L Glutamine Therapy for Sickle Cell Anemia and Sickle beta0-Thalassemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Glutamine (Primary) ; Maltodextrin
- Indications Beta-thalassaemia; Sickle cell anaemia
- Focus Therapeutic Use
- Sponsors Emmaus Medical
- 13 Jan 2014 New trial record
- 13 Jan 2014 New trial record